HL is an uncommon malignancy. In the UK, there were 2086 new cases of HL between 2014 and 2016.[5] In the US, it is estimated that 8100 new cases will be diagnosed in 2019, with approximately 1000 deaths.[6] The age-adjusted incidence rate in the US between 2012 and 2016 was 2.7/100,000 people per year.[6] Median age at diagnosis is 39 years; the risk of HL is higher in men than women.[6] In the US, white people, black people, and non-Hispanic people have a similar risk (which is higher than other racial/ethnic groups including Asians/Pacific Islanders, American Indians/Alaska Natives, and Hispanic people).[6]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer